Snapshot · Medtronic plc (MDT)

Data as of 2026-09-01T23:03:44.458Z

Fundamentals check

Market cap

$117.8B

P/E (TTM)

22.5

Gross margin

66.7%

Net margin

13.9%

ROE

14.2%

R&D / revenue

7.8%

Dividend yield

3.1%

FCF yield

5.2%

Latest dividend: $0.72/share (ex-date 2026-09-25, quarterly)

Summary

Medtronic plc is a leading global medical technology enterprise that invents, develops, manufactures, and distributes an extensive range of device-based medical therapies. These solutions serve healthcare systems, clinicians, physicians, and patients across the world. The company's operations are categorized into several key portfolios: Cardiovascular Portfolio: This segment focuses on cardiac health, providing technologies for heart rhythm management, including implantable pacemakers, defibrillators, and monitoring systems, alongside cardiac ablation tools and remote patient software. It also addresses structural heart issues with products like aortic and pulmonary valves, surgical repair devices, and endovascular stent grafts, in addition to offerings for percutaneous coronary interventions (e.g., angioplasty balloons). Medical Surgical Portfolio: Offering a broad spectrum of surgical instruments and therapies, this division includes staples, vessel sealing devices, wound closure products, and electrosurgical equipment. It also pioneers surgical artificial intelligence and robotic-assisted platforms, alongside solutions for hernia repair, gynecology, lung conditions, minimally invasive gastrointestinal and hepatologic diagnostics, patient monitoring, airway management, ventilation therapies, and renal disease. Neuroscience Portfolio: This division delivers specialized products for a diverse group of medical professionals, such as spinal surgeons, neurosurgeons, neurologists, pain management specialists, and ENT experts. Its offerings span energy surgical instruments, advanced image-guided and intra-operative imaging systems, robotic guidance for spine procedures, and therapies targeting the brain's vasculature. Diabetes Operating Unit: Dedicated to diabetes management, this unit provides innovative solutions like insulin pumps and their associated consumables, continuous glucose monitoring (CGM) systems, and smart insulin pen technologies. Established in 1949, Medtronic plc maintains its corporate headquarters in Dublin, Ireland.

How it makes money

Revenue mix, latest fiscal year

• Cardiac and Vascular Group38.6%
• Neuroscience Group28.4%
• Medical Surgical24.4%
• Diabetes Group8.6%

Recent Events

• 2026-08-31T13:30:05.000Zneutral

  Brokers Suggest Investing in Medtronic (MDT): Read This Before Placing a Bet

  可能与经纪商建议相关，存在投资偏见的风险，不构成直接因果关系。

  Source: Zacks Investment Research

• 2026-08-28T06:03:51.000Zpositive

  Medtronic Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

  可能与公司盈利前景相关，基于分析师调低/提升预测，需结合实际披露判断，不构成因果结论。

  Source: benzinga.com

• 2026-08-27T13:15:05.000Zpositive

  Insights Into Medtronic (MDT) Q1: Wall Street Projections for Key Metrics

  可能与Q1盈利目标和收入增长展望相关，分析师普遍看好部分板块，存在不确定性。

  Source: Zacks Investment Research

• 2026-08-20T16:50:00.000Zneutral

  Medtronic announces cash dividend for second quarter of fiscal year 2027

  可能与股息公告相关，反映公司现金分配政策，非直接盈利驱动因素。

  Source: prnewswire.com

• 2026-07-16T00:00:00.000Zpositive

  Price move: MDT rose 3.8%

  MDT 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-07-14T00:00:00.000Znegative

  Price move: MDT fell 5.1%

  MDT 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

• 2026-06-17T00:00:00.000Znegative

  Price move: MDT fell 3.9%

  MDT 在这段行情中出现明显波动，恰逢异常的价格变动，但此处没有可关联到的具体新闻事件。

Analyst view

Avg price target $93.13 from 16 analysts (last quarter)

Insider & Congress activity

Open-market trades only; grants and exercises excluded

• 2026-07-08SellWalter Matthew R.(officer: SVP, Chief HR Officer)3,102 shares
• 2026-06-08SellKIIL HARRY SKIP(officer: EVP & President Cardiovascular)228 shares
• 2026-06-08SellKIIL HARRY SKIP(officer: EVP & President Cardiovascular)3,961 shares

Earnings Calendar

2026-11-17

EPS estimate: 1.35

订阅每日简报

每个交易日开盘/收盘后，中文市场简报直达邮箱。免费，随时退订。

本内容仅为信息整理，不构成任何投资建议。